Literature DB >> 16970943

Sphingolipids in cancer: regulation of pathogenesis and therapy.

Besim Ogretmen1.   

Abstract

Sphingolipids are known to play important roles in the regulation of cell proliferation, response to chemotherapeutic agents, and/or prevention of cancer. Recently, significant progress has been made in the identification of the enzymes and their biochemical functions involved in sphingolipid metabolism. In addition, development of new techniques for the quantitative analysis of sphingolipids at their physiological levels has facilitated studies to examine distinct functions of these bioactive sphingolipids in cancer pathogenesis and therapy. This review will focus on the recent developments regarding the roles of bioactive sphingolipids in the regulation of cell growth/proliferation, and anti-cancer therapeutics.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16970943     DOI: 10.1016/j.febslet.2006.08.052

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  32 in total

1.  Targeting inhibitor 2 of protein phosphatase 2A as a therapeutic strategy for prostate cancer treatment.

Authors:  Archana Mukhopadhyay; Kayann Tabanor; Rathnam Chaguturu; Jane V Aldrich
Journal:  Cancer Biol Ther       Date:  2013-08-05       Impact factor: 4.742

Review 2.  Sphingolipids and expression regulation of genes in cancer.

Authors:  Gauri A Patwardhan; Yong-Yu Liu
Journal:  Prog Lipid Res       Date:  2010-10-21       Impact factor: 16.195

Review 3.  Ceramide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistance.

Authors:  Yong-Yu Liu; Ronald A Hill; Yu-Teh Li
Journal:  Adv Cancer Res       Date:  2013       Impact factor: 6.242

4.  Sphingosine-1-phosphate rapidly increases cortisol biosynthesis and the expression of genes involved in cholesterol uptake and transport in H295R adrenocortical cells.

Authors:  Natasha C Lucki; Donghui Li; Marion B Sewer
Journal:  Mol Cell Endocrinol       Date:  2011-08-16       Impact factor: 4.102

5.  Identification of Double Bond Position Isomers in Unsaturated Lipids by m-CPBA Epoxidation and Mass Spectrometry Fragmentation.

Authors:  Yu Feng; Bingming Chen; Qinying Yu; Lingjun Li
Journal:  Anal Chem       Date:  2019-01-17       Impact factor: 6.986

6.  Ceramide Suppresses Influenza A Virus Replication In Vitro.

Authors:  Nadia Soudani; Rouba Hage-Sleiman; Walid Karam; Ghassan Dbaibo; Hassan Zaraket
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

7.  Ceramide signaling in cancer and stem cells.

Authors:  Erhard Bieberich
Journal:  Future Lipidol       Date:  2008-06

8.  PhotoImmunoNanoTherapy reveals an anticancer role for sphingosine kinase 2 and dihydrosphingosine-1-phosphate.

Authors:  Brian M Barth; Sriram S Shanmugavelandy; James M Kaiser; Christopher McGovern; Erhan İ Altınoğlu; Jeremy K Haakenson; Jeremy A Hengst; Evan L Gilius; Sarah A Knupp; Todd E Fox; Jill P Smith; Timothy M Ritty; James H Adair; Mark Kester
Journal:  ACS Nano       Date:  2013-02-14       Impact factor: 15.881

9.  Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2.

Authors:  Kevin J French; Yan Zhuang; Lynn W Maines; Peng Gao; Wenxue Wang; Vladimir Beljanski; John J Upson; Cecelia L Green; Staci N Keller; Charles D Smith
Journal:  J Pharmacol Exp Ther       Date:  2010-01-08       Impact factor: 4.030

10.  Clinical relevance of ceramide metabolism in the pathogenesis of human head and neck squamous cell carcinoma (HNSCC): attenuation of C(18)-ceramide in HNSCC tumors correlates with lymphovascular invasion and nodal metastasis.

Authors:  Serdar Karahatay; Kesha Thomas; Serap Koybasi; Can E Senkal; Saeed Elojeimy; Xiang Liu; Jacek Bielawski; Terry A Day; M Boyd Gillespie; Debajyoti Sinha; James S Norris; Yusuf A Hannun; Besim Ogretmen
Journal:  Cancer Lett       Date:  2007-07-09       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.